204 related articles for article (PubMed ID: 31025383)
1. Induction of CD137 expression by viral genes reduces T cell costimulation.
Wu M; Wong HY; Lin JL; Moliner A; Schwarz H
J Cell Physiol; 2019 Nov; 234(11):21076-21088. PubMed ID: 31025383
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T Cells Inhibit T Cell Activity by Downregulating CD137 Ligand via CD137 Trogocytosis.
Luu K; Patwardhan MV; Zeng Q; Wickström SL; Lundqvist A; Schwarz H
Cells; 2021 Feb; 10(2):. PubMed ID: 33572150
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors.
Prasad M; Ponnalagu S; Zeng Q; Luu K; Lang SM; Wong HY; Cheng MS; Wu M; Mallilankaraman K; Sobota RM; Lim YT; Wang LC; Goh CK; Tay KXJ; Loh KS; Wang CI; Lee WH; Goh BC; Lim CM; Schwarz H
Cancer Immunol Immunother; 2022 Nov; 71(11):2583-2596. PubMed ID: 35299256
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD137 on Hodgkin and Reed-Sternberg cells inhibits T-cell activation by eliminating CD137 ligand expression.
Ho WT; Pang WL; Chong SM; Castella A; Al-Salam S; Tan TE; Moh MC; Koh LK; Gan SU; Cheng CK; Schwarz H
Cancer Res; 2013 Jan; 73(2):652-61. PubMed ID: 23204227
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand.
Kang SW; Lee SC; Park SH; Kim J; Kim HH; Lee HW; Seo SK; Kwon BS; Cho HR; Kwon B
Cancer Res; 2017 Nov; 77(21):5989-6000. PubMed ID: 28923858
[TBL] [Abstract][Full Text] [Related]
6. CD137 / CD137 ligand signalling regulates the immune balance: A potential target for novel immunotherapy of autoimmune diseases.
Wong HY; Schwarz H
J Autoimmun; 2020 Aug; 112():102499. PubMed ID: 32505443
[TBL] [Abstract][Full Text] [Related]
7. The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity.
Choi BK; Lee HW
Front Immunol; 2020; 11():553715. PubMed ID: 33362756
[TBL] [Abstract][Full Text] [Related]
8. The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus.
Mak A; Schwarz H
Cells; 2019 Sep; 8(9):. PubMed ID: 31500130
[TBL] [Abstract][Full Text] [Related]
9. Bayesian approach to model CD137 signaling in human M. tuberculosis in vitro responses.
Fernández Do Porto DA; Auzmendi J; Peña D; García VE; Moffatt L
PLoS One; 2013; 8(2):e55987. PubMed ID: 23437083
[TBL] [Abstract][Full Text] [Related]
10. The CD137 Ligand Is Important for Type 1 Diabetes Development but Dispensable for the Homeostasis of Disease-Suppressive CD137
Foda BM; Ciecko AE; Serreze DV; Ridgway WM; Geurts AM; Chen YG
J Immunol; 2020 Jun; 204(11):2887-2899. PubMed ID: 32295876
[TBL] [Abstract][Full Text] [Related]
11. CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8
Dharmadhikari B; Nickles E; Harfuddin Z; Ishak NDB; Zeng Q; Bertoletti A; Schwarz H
Cancer Immunol Immunother; 2018 Jun; 67(6):893-905. PubMed ID: 29508025
[TBL] [Abstract][Full Text] [Related]
12. Concomitant
Rodriguez R; Fournier B; Cordeiro DJ; Winter S; Izawa K; Martin E; Boutboul D; Lenoir C; Fraitag S; Kracker S; Watts TH; Picard C; Bruneau J; Callebaut I; Fischer A; Neven B; Latour S
J Exp Med; 2019 Dec; 216(12):2800-2818. PubMed ID: 31537641
[TBL] [Abstract][Full Text] [Related]
13. CD137 ligand reverse signaling skews hematopoiesis towards myelopoiesis during aging.
Tang Q; Koh LK; Jiang D; Schwarz H
Aging (Albany NY); 2013 Sep; 5(9):643-52. PubMed ID: 23945137
[TBL] [Abstract][Full Text] [Related]
14. CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells.
Baessler T; Charton JE; Schmiedel BJ; Grünebach F; Krusch M; Wacker A; Rammensee HG; Salih HR
Blood; 2010 Apr; 115(15):3058-69. PubMed ID: 20008791
[TBL] [Abstract][Full Text] [Related]
15. Identification of CD137- and CD137L-Expressing Cells in EL-4 Tumor.
Kang SW; Cho HR; Kwon B
Methods Mol Biol; 2021; 2248():221-229. PubMed ID: 33185879
[TBL] [Abstract][Full Text] [Related]
16. Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.
Maniar A; Zhang X; Lin W; Gastman BR; Pauza CD; Strome SE; Chapoval AI
Blood; 2010 Sep; 116(10):1726-33. PubMed ID: 20519625
[TBL] [Abstract][Full Text] [Related]
17. CD137 differentially regulates innate and adaptive immunity against Mycobacterium tuberculosis.
Fernández Do Porto DA; Jurado JO; Pasquinelli V; Alvarez IB; Aspera RH; Musella RM; García VE
Immunol Cell Biol; 2012 Apr; 90(4):449-56. PubMed ID: 21747409
[TBL] [Abstract][Full Text] [Related]
18. Ectopic CD137 expression by rhabdomyosarcoma provides selection advantages but allows immunotherapeutic targeting.
Lee KY; Wong HY; Zeng Q; Le Lin J; Cheng MS; Kuick CH; Chang KTE; Loh AHP; Schwarz H
Oncoimmunology; 2021 Feb; 10(1):1877459. PubMed ID: 33643694
[TBL] [Abstract][Full Text] [Related]
19. CD137L-DCs, Potent Immune-Stimulators-History, Characteristics, and Perspectives.
Zeng Q; Zhou Y; Schwarz H
Front Immunol; 2019; 10():2216. PubMed ID: 31632390
[TBL] [Abstract][Full Text] [Related]
20. Trogocytic CD137 transfer causes an internalization of CD137 ligand on murine APCs leading to reduced T cell costimulation.
Shao Z; Harfuddin Z; Pang WL; Nickles E; Koh LK; Schwarz H
J Leukoc Biol; 2015 May; 97(5):909-919. PubMed ID: 25765680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
